In Saving Lives...
SPEED IS ESSENTIAL
We are rapidly developing novel solutions for the most pressing healthcare needs
AntagenPharma has a robust biologics pipeline targeting a range of unmet needs in infection, cancer and autoimmune diseases
To protect people infected with COVID-19, we expedite the development of biologics as countermeasures against Acute Respiratory Distress Syndrome
AntagenPharma has pioneered biologics development through its high-performance protein & antibody mammalian cell expression platforms and glyco-engineered CHO cell expression technologies
We are dedicated to fighting against infectious, cancerous and autoimmune diseases through novel scientific approaches, especially containing COVID-19 epidemic